Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,861 | -15,712 | -6,027 | -1,809 | -189 |
| Depreciation Amortization | 1,440 | 926 | 466 | 1,753 | 1,204 |
| Income taxes - deferred | -193 | -312 | -87 | -38 | -250 |
| Accounts receivable | 2,590 | 8,496 | -94 | -4,263 | -6,686 |
| Accounts payable and accrued liabilities | -612 | -1,036 | 1,814 | -360 | 325 |
| Other Working Capital | -2,385 | 2,884 | -2,045 | -11,263 | -11,452 |
| Other Operating Activity | 2,114 | -4,550 | 441 | 8,817 | 9,702 |
| Operating Cash Flow | $-12,907 | $-9,304 | $-5,532 | $-7,163 | $-7,346 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,974 | -2,414 | -605 | -1,658 | -729 |
| Investing Cash Flow | $-3,974 | $-2,414 | $-605 | $-1,658 | $-729 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 99 | 58 | 1 | 4,035 | 3,926 |
| Common Stock Repurchased | -7,732 | -7,732 | -7,732 | -6,992 | -3,325 |
| Other Financing Activity | -189 | -165 | -155 | -224 | -224 |
| Financing Cash Flow | $-7,822 | $-7,839 | $-7,886 | $-3,181 | $377 |
| Exchange Rate Effect | -593 | -871 | -909 | 428 | -864 |
| Beginning Cash Position | 181,370 | 181,370 | 181,370 | 192,944 | 192,944 |
| End Cash Position | 160,721 | 165,589 | 166,585 | 181,370 | 184,382 |
| Net Cash Flow | $-20,649 | $-15,781 | $-14,785 | $-11,574 | $-8,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,907 | -9,304 | -5,532 | -7,163 | -7,346 |
| Capital Expenditure | -3,974 | -2,414 | -605 | -1,658 | -729 |
| Free Cash Flow | -16,881 | -11,718 | -6,137 | -8,821 | -8,075 |